Research Misconduct in FDA-Regulated Clinical Trials

  • A Cross-sectional Analysis of Warning Letters and Disqualification Proceedings
  • Craig A. Garmendia, Neera Bhansali, Purnima Madhivanan
  • Therapeutic Innovation & Regulatory Science, January 2018, SAGE Publications
  • DOI: 10.1177/2168479017749514

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1177/2168479017749514

The following have contributed to this page: Craig Garmendia